Gladson C L, Schleef R R, Binder B R, Loskutoff D J, Griffin J H
Research Institute of Scripps Clinic, Department of Immunology, La Jolla, CA 92037.
Blood. 1989 Jul;74(1):173-81.
This study investigates the role of the gamma-carboxyglutamic acid (gla) containing domain of activated protein C in interactions with both platelet-derived and purified type 1 plasminogen activator inhibitor (PAI-1). The activity of human platelet PAI-1 was neutralized to the same extent by bovine activated protein C and bovine des-1-41-light chain-activated protein C. Both forms of activated protein C formed SDS-stable, divalent-cation independent complexes with platelet PAI-1, as demonstrated by immunoblotting using antibodies directed to either protein C or PAI-1. Since activated protein C neutralized PAI-1, the potential inhibition of the enzyme by PAI-1 was studied. Purified PAI-1 inhibited the amidolytic activity of bovine-activated protein C and bovine des-1-41-light chain-activated protein C with a k2 of 2.85 X 10(4) M-1 sec-1 for both proteins. These data suggest that the gla domain of activated protein C is not required for neutralization of PAI-1 activity, for complex formation with PAI-1, or for inhibition of the amidolytic activity of activated protein C by PAI-1.
本研究调查了活化蛋白C中含γ-羧基谷氨酸(gla)结构域在与血小板源性及纯化的1型纤溶酶原激活物抑制剂(PAI-1)相互作用中的作用。牛活化蛋白C和牛去1-41轻链活化蛋白C对人血小板PAI-1活性的中和程度相同。通过使用针对蛋白C或PAI-1的抗体进行免疫印迹证明,两种形式的活化蛋白C均与血小板PAI-1形成了SDS稳定的、不依赖二价阳离子的复合物。由于活化蛋白C中和了PAI-1,因此研究了PAI-1对该酶的潜在抑制作用。纯化的PAI-1对牛活化蛋白C和牛去1-41轻链活化蛋白C的酰胺水解活性均有抑制作用,两种蛋白的k2均为2.85×10⁴ M⁻¹ s⁻¹。这些数据表明,活化蛋白C的gla结构域对于PAI-1活性的中和、与PAI-1形成复合物或PAI-1对活化蛋白C酰胺水解活性的抑制均非必需。